Infusion pumps: T34 syringe drivers

AI Summary

This summary addresses the safety concerns surrounding T34 syringe drivers, manufactured by BD (formerly CME Medical). Following various safety alerts issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA), an assessment of the devices revealed significant technical vulnerabilities. The primary issues involve inconsistent performance between different software versions (Version 2 and Version 3), battery drainage problems, and risks of over-infusion or under-infusion due to sensor sensitivities and mechanical failures. These malfunctions pose a direct risk to patient safety, particularly in palliative care settings where accurate dosing is critical. Under the UK Medical Devices Regulations 2002, the MHRA mandated specific risk mitigation measures. Healthcare organizations must conduct comprehensive audits of their device fleets to identify and segregate different software versions to prevent clinician confusion. Required actions include updating all units to the latest software standard, providing mandatory staff retraining on pump operation, and ensuring that maintenance is performed only by certified technicians. Furthermore, providers are instructed to phase out older hardware that cannot support necessary safety patches. Ongoing monitoring of device performance is essential to ensure compliance with clinical safety standards and to mitigate the risk of adverse events during medication delivery.